DUBA 9 February 2021: The Ministry of Health and Prevention (MoHAP) has issued a decision withdrawing a number of pharmaceutical products manufactured by Julphar, the Gulf Pharmaceutical Industries PSC, after being found non-compliant with approved […]
RAS AL KHAIMAH 16 July 2020: Gulf Pharmaceutical Industries (Julphar), announced that its Dh500 million rights issue was successfully completed and more than two times oversubscribed. According to a press release issued by Julphar on […]
RAS AL KHAIMAH 2 June 2020: Gulf Pharmaceutical Industries (Julphar), on Monday announced the launch of its Dh500 million rights issue as the company progresses on its ambitious turnaround plan. The rights issue is set […]
DUBAI 19 August 2019: The Ministry of Health and Prevention (MoHAP) has issued a circular withdrawing batch No.0093 of the pharmaceutical product (Laxocodyl suppositories10mg) after finding a mistake on the outside label. The medicine label […]